- Assessing the Optimal Cutpoint for Tumor Size in Patients with Lung Cancer Based on Linear Rank Statistics in a Competing Risks Framework
-
Kim J, Ng HK, Kim SW
- KMID: 2446956
- Yonsei Med J.
- 2019 Jun;60(6):517-524.
- doi: 10.3349/ymj.2019.60.6.517
PURPOSE: In clinical studies, patients may experience several types of events during follow up under the competing risks (CR) framework. Patients are often classified into low- and high-risk groups based... -
- CITED
-
- Close
- SHARE
-
- Close
